Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP735239.RASvdLCD5XUfUMoQ74kBsC65bgKbIgblUQ-izTLAK6G3I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP735239.RASvdLCD5XUfUMoQ74kBsC65bgKbIgblUQ-izTLAK6G3I130_assertion type Assertion NP735239.RASvdLCD5XUfUMoQ74kBsC65bgKbIgblUQ-izTLAK6G3I130_head.
- NP735239.RASvdLCD5XUfUMoQ74kBsC65bgKbIgblUQ-izTLAK6G3I130_assertion description "[To investigate catecholamine phenotypes and the effects of a tyrosine hydroxylase inhibitor in individuals with the 22q11.2 deletion syndrome and low-activity catechol-O-methyltransferase (COMT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP735239.RASvdLCD5XUfUMoQ74kBsC65bgKbIgblUQ-izTLAK6G3I130_provenance.
- NP735239.RASvdLCD5XUfUMoQ74kBsC65bgKbIgblUQ-izTLAK6G3I130_assertion evidence source_evidence_literature NP735239.RASvdLCD5XUfUMoQ74kBsC65bgKbIgblUQ-izTLAK6G3I130_provenance.
- NP735239.RASvdLCD5XUfUMoQ74kBsC65bgKbIgblUQ-izTLAK6G3I130_assertion SIO_000772 11502905 NP735239.RASvdLCD5XUfUMoQ74kBsC65bgKbIgblUQ-izTLAK6G3I130_provenance.
- NP735239.RASvdLCD5XUfUMoQ74kBsC65bgKbIgblUQ-izTLAK6G3I130_assertion wasDerivedFrom befree-20150227 NP735239.RASvdLCD5XUfUMoQ74kBsC65bgKbIgblUQ-izTLAK6G3I130_provenance.
- NP735239.RASvdLCD5XUfUMoQ74kBsC65bgKbIgblUQ-izTLAK6G3I130_assertion wasGeneratedBy ECO_0000203 NP735239.RASvdLCD5XUfUMoQ74kBsC65bgKbIgblUQ-izTLAK6G3I130_provenance.